KarmelSonix Ltd. - 2007 Annual Report

PulmoTrack® Sales to Pharmacy Group in Australia Commence
(27/06/2008)
US – Israel Binational R&D Foundation Approves Funding of Joint Venture WIM-GER™ Development
(18/06/2008)
Clinical Study Confirms Utility of Acoustic Transmission Technology in Assessing Asthma
(17/06/2008)
PulmoTrack® starts selling in Europe, China, and Taiwan
(12/06/2008)
Karmelsonix periodic newspaper – The Sound Evidence Times
WIM-PC™ Receives FDA Approval
(04/11/2007)

Home >> Investor Relations >> 2007 Annual Report

2007 Annual Report>>

"The 2006/07 financial year was one of transition for KarmelSonix Ltd (“KSX”), incorporating a move into the area of respiratory medicine combined with a strong focus on early commercialisation of the novel devices being developed by the Company..."

[Top] [Add to Favorites] [Site Map]